MasSpec Pen shows promise in pancreatic cancer surgery
E-Mail IMAGE: Dr. James Suliburk, head of endocrine surgery at Baylor College of Medicine, using the MasSpec Pen during a surgery. view more Credit: James Suliburk/Baylor College of Medicine AUSTIN, Texas -- A diagnostic tool called the MasSpec Pen has been tested for the first time in pancreatic cancer patients during surgery. The device is shown to accurately identify tissues and surgical margins directly in patients and differentiate healthy and cancerous tissue from banked pancreas samples. At about 15 seconds per analysis, the method is more than 100 times as fast as the curr...
Source: eurekalert.org